Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
Cyclin A2 (BF683) Mouse mAb 4656 40 µl
Western Blotting Flow Cytometry
H 55 Mouse IgE
Cyclin B1 Antibody 4138 40 µl
Western Blotting Immunofluorescence
H M R Hm Mk 55 Rabbit 
Cyclin D1 (92G2) Rabbit mAb 2978 40 µl
Western Blotting Immunohistochemistry Flow Cytometry
H M R 36 Rabbit IgG
Cyclin D2 (D52F9) Rabbit mAb 3741 40 µl
Western Blotting Immunoprecipitation
H M R 31 Rabbit IgG
Cyclin D3 (DCS22) Mouse mAb 2936 40 µl
Western Blotting Immunohistochemistry
H M R 31 Mouse IgG1
Cyclin E1 (HE12) Mouse mAb 4129 40 µl
Western Blotting
H M R Hm Mk 48-56 Mouse IgG1
Cyclin E2 Antibody 4132 40 µl
Western Blotting
H 48 Rabbit 
Cyclin H Antibody 2927 40 µl
Western Blotting Immunoprecipitation
H M R 36 Rabbit 
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 
Anti-mouse IgG, HRP-linked Antibody 7076 100 µl
Western Blotting
All Horse 

Product Description

The Cyclin Antibody Sampler Kit provides an economical means of evaluating the presence of cyclin proteins in cells. The kit contains enough primary and secondary antibodies to perform four western blot experiments with each antibody.


Specificity / Sensitivity

Each antibody in the Cyclin Antibody Sampler Kit detects endogenous levels of its respective target protein and does not cross-react with other cyclin proteins.


Source / Purification

Monoclonal antibody is produced by immunizing animals with synthetic peptides corresponding to residues within the carboxy terminus of cyclin D1, the amino terminus of cyclin D2, recombinant human cyclin E1, or cyclin A2. Polyclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues within the carboxy terminus of cyclin H, cyclin E2, or the amino terminus of cyclin B. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.

Control of the cell cycle is regulated by a multitude of cellular events and processes. The cyclin dependent kinases (CDK) regulate many of these pathways and constitute an active complex when associated with their cyclin partners. This activity is controlled primarily by phosphorylation, which determines subcellular localization of the CDK/cyclin complex (1,2). Some phosphorylation events control the function of cytoplasmic retention sequences while other events regulate nuclear localization and export sequence function (3,4). Cyclin and cyclin-dependent kinase inhibitor (CKI) levels are regulated by ubiquitination and degradation via the ubiquitin proteasome pathway (5). A variety of CKI proteins associate with these complexes and modulate access to regulatory domains on cyclins (6). Additional complexity is generated as the controlled protein levels of each cyclin oscillate with the stages of cell cycle. Increased expression of Cyclin D1 is associated with certain types of cancer (7,8) and may associate with TSC2 (tuberin) independent of its Cdk partner (9).


1.  Krempler, A. et al. (2005) Cell Mol Life Sci 62, 1379-87.

2.  Sherr, C.J. (1996) Science 274, 1672-7.

3.  Toyoshima, F. et al. (1998) EMBO J 17, 2728-35.

4.  Hirai, H. et al. (1995) Mol Cell Biol 15, 2672-81.

5.  Porter, L.A. and Donoghue, D.J. (2003) Prog Cell Cycle Res 5, 335-47.

6.  Benzeno, S. et al. (2006) Oncogene 25, 6291-303.

7.  Diehl, J.A. et al. (1997) Genes Dev. 11, 957-972.

8.  Kim, J.K. and Diehl, J.A. (2009) J Cell Physiol 220, 292-6.

9.  Zacharek, S.J. et al. (2005) Cancer Res 65, 11354-60.


Entrez-Gene Id 890 , 891 , 595 , 894 , 896 , 898 , 9134 , 902
Swiss-Prot Acc. P20248 , P14635 , P24385 , P30279 , P30281 , P24864 , O96020 , P51946


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.